You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 1, July 6, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Women's Health, Other
 •Oncology
 •Alert me on articles by topic

Low-Dose Aspirin and Vitamin E

Challenges and Opportunities in Cancer Prevention

Eric J. Jacobs, PhD; Michael J. Thun, MD

JAMA. 2005;294:105-106.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This issue of JAMA includes 2 articles from the Women’s Health Study (WHS).1-2 This 10-year long, placebo-controlled, randomized trial of low-dose aspirin and vitamin E included nearly 40 000 predominantly middle-aged women with no history of cancer or cardiovascular disease.3 The WHS used a 2 x 2 factorial design to evaluate the effects of low-dose aspirin (100 mg) taken every other day and 600 IU of vitamin E (in the form of natural-source {alpha}-tocopherol), also taken every other day. Neither alternate-day, low-dose aspirin nor vitamin E showed any evidence of efficacy in reducing overall cancer incidence or mortality.1-2 With respect to noncancer outcomes, notable findings for low-dose aspirin included a reduction in stroke risk, no apparent effect on myocardial infarction, and an increased risk of gastrointestinal bleeding requiring transfusion.4 Vitamin E had no apparent effect on either cardiovascular disease incidence or on gastrointestinal . . . [Full Text of this Article]

Author Affiliations: Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Ga.


RELATED ARTICLES

Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial
Nancy R. Cook, I-Min Lee, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):47-55.
ABSTRACT | FULL TEXT  

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New Women's Health Study Data on Vitamin E and Aspirin
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.